InvestorsHub Logo
Followers 743
Posts 62198
Boards Moderated 11
Alias Born 10/05/2009

Re: Golf4Food post# 441

Tuesday, 02/07/2012 10:57:53 AM

Tuesday, February 07, 2012 10:57:53 AM

Post# of 1439
From what I can tell so far, there is a much larger drug pipeline now. MHAN (now TGTX) had 3 products plus the JV on Hedrin before the merger early last year that added 2 new drugs, including the B-12, then the merger at the end of the year last year added at least one new block buster product (oncology Cancer drug) with lots of cash and funding from the France company to get into the US market, and now yesterdays drug(s?) acquisition which also brought in more cash ($10 million plus???).

There should be steady news flow on all these products this year, with funding already in house to get the ball moving on many trials and maybe even an NDA at the FDA this year? They also might sell or JV something from the prior pipeline. Also, it looks like all the new shares are currently restricted, and the float is about 1% of total share count, so this stock could run hard into $$ dollars for 6 months due to the lack of trade-able shares for now, as evidenced by yesterdays huge move.

Add in the fact that no one was watching or trading this one, and any more news any time soon may send it over $1 very quickly.

Ambition with out knowledge is like ship in dry dock. Going nowhere fast!